July 14, 2024 This Week Top S&P 500 Gainers & Losers
Tesla Q2: The Bottom Is Likely In
Tesla: Time To Take Profits
Microsoft: The Q4 Results Should Surprise You
Tesla: Optimus And FSD Probably Won’t Save The Day
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Calliditas Therapeutics (CALT) Stock Forecast for 2024–2028. Sell or Buy?
Updated: July 27, 2024 (10:06)
Sector: HealthcareThe share price of Calliditas Therapeutics AB (publ) (CALT) now
50/200 Day Moving Average: $35.96 / $24.32
This figure corresponds to the Average Price over the previous 50/200 days. For Calliditas Therapeutics stocks, the 50-day moving average is the support level today.
For Calliditas Therapeutics stocks, the 200-day moving average is the support level today.
Are you interested in Calliditas Therapeutics AB (publ) stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Calliditas Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Calliditas Therapeutics share be worth in 2024 - 2028?
When should I take profit in Calliditas Therapeutics stock? When should I record a loss on Calliditas Therapeutics stock? What are analysts' forecasts for Calliditas Therapeutics stock? What is the future of Calliditas Therapeutics stock? We forecast Calliditas Therapeutics stock performance using neural networks based on historical data on Calliditas Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Calliditas Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Calliditas Therapeutics shares. This happens once a day.
Historical and forecast chart of Calliditas Therapeutics stock
The chart below shows the historical price of Calliditas Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Calliditas Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, has focused on identifying, developing and commercializing pharmaceutical products for the treatment of orphan symptoms with an initial focus on kidney and liver diseases. The main candidate for the company’s products is Nefekon, an oral budesonide drug that is an immunosuppressive agent for the treatment of autoimmune IgA renal nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden.
Calliditas Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul 29 | 40.22 | 38.81 | 41.57 | 7.10 |
| Jul 30 | 40.44 | 39.59 | 41.05 | 3.68 |
| Jul 31 | 41.07 | 40.66 | 42.22 | 3.84 |
| Aug 01 | 41.37 | 40.51 | 42.53 | 5.01 |
| Aug 02 | 43.09 | 41.88 | 44.08 | 5.25 |
| Aug 03 | 42.62 | 41.70 | 43.68 | 4.75 |
| Aug 04 | 42.64 | 42.19 | 43.83 | 3.89 |
| Aug 05 | 43.19 | 42.63 | 44.53 | 4.46 |
| Aug 06 | 42.63 | 41.69 | 43.44 | 4.19 |
| Aug 07 | 43.46 | 42.94 | 44.92 | 4.61 |
| Aug 08 | 41.85 | 40.89 | 43.28 | 5.83 |
| Aug 09 | 43.80 | 42.86 | 45.42 | 5.98 |
| Aug 10 | 42.92 | 41.44 | 44.62 | 7.66 |
| Aug 11 | 44.71 | 43.19 | 46.23 | 7.04 |
| Aug 12 | 45.11 | 43.98 | 45.72 | 3.95 |
| Aug 13 | 44.84 | 43.31 | 46.36 | 7.04 |
| Aug 14 | 44.32 | 43.66 | 44.77 | 2.54 |
| Aug 15 | 43.79 | 43.18 | 44.80 | 3.75 |
| Aug 16 | 43.55 | 43.01 | 44.55 | 3.59 |
| Aug 17 | 44.27 | 43.16 | 45.06 | 4.41 |
| Aug 18 | 44.09 | 43.36 | 44.73 | 3.15 |
| Aug 19 | 44.82 | 43.83 | 45.51 | 3.83 |
| Aug 20 | 46.25 | 45.12 | 47.94 | 6.25 |
| Aug 21 | 45.17 | 43.77 | 45.82 | 4.70 |
| Aug 22 | 45.23 | 43.72 | 46.34 | 6.00 |
| Aug 23 | 47.45 | 45.84 | 48.64 | 6.11 |
| Aug 24 | 46.19 | 45.15 | 47.79 | 5.83 |
| Aug 25 | 44.88 | 44.20 | 46.18 | 4.47 |
| Aug 26 | 45.19 | 44.49 | 46.48 | 4.47 |
| Aug 27 | 46.14 | 44.50 | 47.18 | 6.01 |
Calliditas Therapeutics Daily Price Targets
Calliditas Therapeutics Stock Forecast 07-29-2024.
Forecast target price for 07-29-2024: $40.22.
Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 6.628%.
Pessimistic target level: 38.81
Optimistic target level: 41.57
Calliditas Therapeutics Stock Forecast 07-30-2024.
Forecast target price for 07-30-2024: $40.44.
Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 3.547%.
Pessimistic target level: 39.59
Optimistic target level: 41.05
Calliditas Therapeutics Stock Forecast 07-31-2024.
Forecast target price for 07-31-2024: $41.07.
Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 3.696%.
Pessimistic target level: 40.66
Optimistic target level: 42.22
Calliditas Therapeutics Stock Forecast 08-01-2024.
Forecast target price for 08-01-2024: $41.37.
Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 4.766%.
Pessimistic target level: 40.51
Optimistic target level: 42.53
Calliditas Therapeutics Stock Forecast 08-02-2024.
Forecast target price for 08-02-2024: $43.09.
Positive dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 4.985%.
Pessimistic target level: 41.88
Optimistic target level: 44.08
Calliditas Therapeutics Stock Forecast 08-03-2024.
Forecast target price for 08-03-2024: $42.62.
Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 4.537%.
Pessimistic target level: 41.70
Optimistic target level: 43.68
CALT (CALT) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Aug. | 44.89 | 41.82 | 46.85 | 10.74 |
| Sep. | 46.17 | 42.75 | 49.94 | 14.40 |
| Oct. | 48.80 | 43.24 | 54.18 | 20.19 |
| Nov. | 42.31 | 37.89 | 48.18 | 21.36 |
| Dec. | 39.34 | 37.09 | 43.67 | 15.06 |
Calliditas Therapeutics forecast for this year
Calliditas Therapeutics Stock Prediction for Aug 2024
An uptrend is forecast for this month with an optimal target price of $44.8911. Pessimistic: $41.82. Optimistic: $46.85
Calliditas Therapeutics Stock Prediction for Sep 2024
An uptrend is forecast for this month with an optimal target price of $46.1705. Pessimistic: $42.75. Optimistic: $49.94
Calliditas Therapeutics Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $48.8022. Pessimistic: $43.24. Optimistic: $54.18
Calliditas Therapeutics Stock Prediction for Nov 2024
An downtrend is forecast for this month with an optimal target price of $42.3115. Pessimistic: $37.89. Optimistic: $48.18
Calliditas Therapeutics Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $39.337. Pessimistic: $37.09. Optimistic: $43.67
Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 42.63 | 37.60 | 47.16 | 20.26 |
| Feb | 38.58 | 35.20 | 44.29 | 20.52 |
| Mar | 35.64 | 30.36 | 39.37 | 22.88 |
| Apr | 35.24 | 31.35 | 37.78 | 17.01 |
| May | 40.93 | 36.65 | 45.98 | 20.29 |
| Jun | 41.63 | 39.57 | 44.71 | 11.50 |
| Jul | 44.87 | 39.67 | 49.05 | 19.12 |
| Aug | 48.71 | 43.90 | 55.46 | 20.86 |
| Sep | 50.10 | 43.81 | 53.81 | 18.57 |
| Oct | 49.62 | 45.10 | 54.90 | 17.86 |
| Nov | 55.47 | 51.67 | 60.42 | 14.48 |
| Dec | 59.47 | 52.01 | 63.31 | 17.85 |
Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 60.94 | 52.83 | 70.20 | 24.74 |
| Feb | 57.12 | 51.58 | 65.26 | 20.95 |
| Mar | 56.79 | 49.78 | 60.25 | 17.37 |
| Apr | 48.70 | 45.09 | 55.27 | 18.42 |
| May | 51.94 | 45.33 | 58.65 | 22.72 |
| Jun | 45.03 | 40.41 | 49.99 | 19.17 |
| Jul | 41.78 | 39.48 | 47.34 | 16.60 |
| Aug | 44.08 | 42.32 | 49.86 | 15.12 |
| Sep | 42.74 | 40.39 | 47.37 | 14.74 |
| Oct | 41.04 | 38.39 | 42.67 | 10.05 |
| Nov | 41.11 | 36.74 | 45.96 | 20.06 |
| Dec | 35.57 | 30.43 | 37.53 | 18.91 |
Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 35.23 | 31.95 | 40.25 | 20.62 |
| Feb | 31.48 | 26.94 | 35.79 | 24.74 |
| Mar | 31.24 | 29.28 | 34.51 | 15.14 |
| Apr | 28.45 | 26.88 | 29.53 | 8.97 |
| May | 30.88 | 26.54 | 34.11 | 22.19 |
| Jun | 29.18 | 24.86 | 31.29 | 20.56 |
| Jul | 30.79 | 27.81 | 33.89 | 17.95 |
| Aug | 35.00 | 31.68 | 38.06 | 16.77 |
| Sep | 32.01 | 30.61 | 34.14 | 10.33 |
| Oct | 30.67 | 29.45 | 34.87 | 15.54 |
| Nov | 29.16 | 27.38 | 32.81 | 16.55 |
| Dec | 31.37 | 28.63 | 34.95 | 18.08 |
Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 32.51 | 27.75 | 34.85 | 20.38 |
| Feb | 30.10 | 25.92 | 32.84 | 21.07 |
| Mar | 31.13 | 29.77 | 35.38 | 15.88 |
| Apr | 33.02 | 30.82 | 35.47 | 13.09 |
| May | 32.89 | 29.08 | 37.08 | 21.57 |
| Jun | 30.21 | 27.68 | 33.94 | 18.43 |
| Jul | 28.83 | 24.50 | 32.44 | 24.48 |
| Aug | 33.48 | 31.13 | 35.77 | 12.98 |
| Sep | 35.84 | 34.00 | 41.22 | 17.51 |
| Oct | 34.95 | 30.64 | 39.27 | 21.98 |
| Nov | 32.03 | 27.16 | 34.10 | 20.35 |
| Dec | 31.54 | 27.77 | 36.28 | 23.46 |
Calliditas Therapeutics information and performance
KUNGSBRON 1, C8, STOCKHOLM, SE
Market capitalization of the Calliditas Therapeutics AB (publ) is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CALT shares in the company outstanding by the market price of one share.
EBITDA of Calliditas Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
